212 related articles for article (PubMed ID: 36477171)
1. Assessment of risk factors in patients with rheumatoid arthritis-associated interstitial lung disease.
Severo CR; Chomiski C; Valle MBD; Escuissato DL; Paiva EDS; Storrer KM
J Bras Pneumol; 2022; 48(6):e20220145. PubMed ID: 36477171
[TBL] [Abstract][Full Text] [Related]
2. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
Salaffi F; Carotti M; Di Carlo M; Tardella M; Giovagnoni A
Medicine (Baltimore); 2019 Sep; 98(38):e17088. PubMed ID: 31567944
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Qiu M; Jiang J; Nian X; Wang Y; Yu P; Song J; Zou S
Respir Res; 2021 Oct; 22(1):264. PubMed ID: 34635095
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
Chen N; Diao CY; Gao J; Zhao DB
Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
[TBL] [Abstract][Full Text] [Related]
6. Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
Arthritis Rheumatol; 2017 Mar; 69(3):542-549. PubMed ID: 27788297
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
[TBL] [Abstract][Full Text] [Related]
8. Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Xie M; Zhu C; Ye Y
BMC Pulm Med; 2023 Jul; 23(1):255. PubMed ID: 37434169
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
[TBL] [Abstract][Full Text] [Related]
11. Assessment of interstitial lung disease among black rheumatoid arthritis patients.
McFarlane IM; Zhaz SY; Bhamra MS; Burza A; Kolla S; Alvarez MR; Koci K; Taklalsingh N; Pathiparampil J; Freeman L; Kaplan I; Kabani N; Ozeri DJ; Watler E; Frefer M; Vaitkus V; Matthew K; Arroyo-Mercado F; Lyo H; Zrodlowski T; Feoktistov A; Sanchez R; Sorrento C; Soliman F; Valdez FR; Dronamraju V; Trevisonno M; Grant C; Clerger G; Amin K; Dawkins M; Green J; Moon J; Fahmy S; Waite SA
Clin Rheumatol; 2019 Dec; 38(12):3413-3424. PubMed ID: 31471819
[TBL] [Abstract][Full Text] [Related]
12. Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.
Md Yusof MY; Kabia A; Darby M; Lettieri G; Beirne P; Vital EM; Dass S; Emery P
Rheumatology (Oxford); 2017 Aug; 56(8):1348-1357. PubMed ID: 28444364
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of methotrexate on lung function and mortality in rheumatoid arthritis-related interstitial lung disease: a retrospective cohort study.
Kim K; Woo A; Park Y; Yong SH; Lee SH; Lee SH; Leem AY; Kim SY; Chung KS; Kim EY; Jung JY; Kang YA; Kim YS; Park MS
Ther Adv Respir Dis; 2022; 16():17534666221135314. PubMed ID: 36346076
[TBL] [Abstract][Full Text] [Related]
14. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease.
Zhang Y; Li H; Wu N; Dong X; Zheng Y
Clin Rheumatol; 2017 Apr; 36(4):817-823. PubMed ID: 28191607
[TBL] [Abstract][Full Text] [Related]
15. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis.
Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J
BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367
[TBL] [Abstract][Full Text] [Related]
16. Predictors and radiological characteristics of rheumatoid arthritis-associated interstitial lung disease in a multi-ethnic Malaysian cohort.
Ong SG; Ding HJ; Zuhanis AH; Aida AA; Norazizah IW
Med J Malaysia; 2022 May; 77(3):292-299. PubMed ID: 35638484
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study.
Manfredi A; Cassone G; Furini F; Gremese E; Venerito V; Atzeni F; Arrigoni E; Della Casa G; Cerri S; Govoni M; Petricca L; Iannone F; Salvarani C; Sebastiani M
Intern Med J; 2020 Sep; 50(9):1085-1090. PubMed ID: 31661185
[TBL] [Abstract][Full Text] [Related]
18. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T
Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347
[TBL] [Abstract][Full Text] [Related]
19. Patterns of interstitial lung disease and mortality in rheumatoid arthritis.
Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586
[TBL] [Abstract][Full Text] [Related]
20. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.
Morisset J; Vittinghoff E; Lee BY; Tonelli R; Hu X; Elicker BM; Ryu JH; Jones KD; Cerri S; Manfredi A; Sebastiani M; Gross AJ; Ley B; Wolters PJ; King TE; Kim DS; Collard HR; Lee JS
Respir Med; 2017 Jun; 127():51-56. PubMed ID: 28502419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
